Abstract
The frequency of venous and arterial thromboses and plasminogen level have been investigated in 78 patients with the antiphospholipid syndrome (APS), including 35 patients with systemic lupus erythematosus (SLE + APS) and 43 patients with primary APS (PAPS). The levels and genotypes of plasminogen activator inhibitor type 1 (PAI-1) were determined in 45 patients with APS (21 patients with SLE + APS and 24 patients with PAPS). A control group included 10 individuals without autoimmune disease signs and thromboses during the observation period and in anamnesis. It has been shown for the first time that for one third of 67 patients with APS and thromboses, high-positive levels of antiphospholipid antibodies (aPL) are associated with low plasminogen levels. The levels of PAI-1 antigen measured by the ELISA method, which detects active, latent and bound to plasminogen activator PAI-1, were compared with frequency of thromboses in APS patients. In one third of 43 patients with APS and thromboses the high and increased levels of PAI-1 were associated with high-positive aPL levels. One of possible mechanisms of this interrelationship was considered. It was shown that arterial and, to a greater extent, venous thromboses are associated with the 4G/5G polymorphism of the PAI-1 gene and high plasma level of the inhibitor in 79% of APS patients. In the presence of the 4G allele SLE + APS patients had higher PAI-1 levels than PAPS patients. The data obtained show that measuring the levels of plasminogen and PAI-1 as well as the 4G/5G polymorphism of the PAI-1 gene associated with thromboses may have the practical importance for identification of high risk of thrombosis in APS patients.
Similar content being viewed by others
Abbreviations
- aCL:
-
anticardiolipin antibodies
- AFK-pNA:
-
p-nitroanilide CHO-Ala-Phe-Lys
- aPL:
-
antiphospholipid anibodies
- APS:
-
antiphospholipid syndrome
- aβ2GPI:
-
anti-β2-glycoprotein 1 antibodies
- β2GPI:
-
β2-glycoprotein 1
- GPL and MPL:
-
international assay units of anticardiolipin antibodies for IgG and IgM, respectively
- LAC:
-
lupus anticoagulant
- PAI-1:
-
plasminogen activator inhibitor-1
- tPA:
-
tissue plasminogen activator
- PAPS:
-
primary antiphospholipid syndrome
- Pg:
-
plasminogen
- SLE:
-
systemic lupus erythematosus
- uPA:
-
urokinase-type plasminogen activator
References
Harris, E.N., Br. J. Haematol., 1990, vol. 74, pp. 1–9.
Eby, C., Clin. Lab. Med., 2009, vol. 29, pp. 305–319.
Koniari, I., Siminelakis, S.N., Baikoussis, N.G., Papadopoulos, G., Goudevenos, J., and Apostolakis, E., J. Cardiothorac. Surg., 2010, vol. 5, pp. 101–110.
Reshetnyak, T.M. and Vavilova, T.V., Klin. Lab. Diagn., 2010, no. 5, pp. 12–22.
Lim, W., in Hematology Am. Soc. Hematol. Educ. Program., 2009, pp. 233–239.
Oosting, J.D., Derksen, R.H., Bobbink, I.W., Hackeng, T.M., Bouma, B.N., and de Groot, P.G., Blood, 1993, vol. 81, pp. 2618–2625.
Chen, P.P. and Giles, I., Curr. Rheumatol. Rep., 2010, vol. 12, pp. 45–52.
Galli, M., J. Thromb. Haemost., 2009, vol. 8, pp. 234–236.
Pengo, V., Ruffatti, A., Legnani, C., Greelle, P., Barcellona, D., Erba, N., Testa, S., Marongiu, F., Bison, E., Denas, G., Banzato, A., Jose, S.P., and Iliceto, S., J. Thromb. Haemost., 2010, vol. 8, pp. 237–242.
Pierangeli, S.S., Chen, P.P., Raschi, E., Scurati, S., Grossi, C., Borghi, M.O., Palomo, I., Harris, E.N., and Meroni, P.L., Semin. Thromb. Hemost., 2008, vol. 34, pp. 236–250.
Krone, K.A., Allen, K.L., and McCrae, K.R., Curr. Rheumatol. Rep., 1999, vol. 13, pp. 53–57.
Forastiero, R. and Martinuzzo, M., Lupus, 2008, vol. 17, pp. 872–877.
Tsakiris, D.A., Marbet, G.A., Makris, P.E., Settas, L., and Duckert, F., Thromb. Haemost., 1989, vol. 61, pp. 175–177.
RuIz-Arguelles, G., RuIz-Arguelles, A., Lobato-Mendizabal, E., DIaz-Gomez, F., Pacheco-Pantoja, E., Drenkard, C., and Alarcón-Segovia, D., Am. J. Hematol., 1991, vol. 37, pp. 9–13.
Keeling, D.M., Campbell, S.J., Mackie, I.J., Machin, S.J., and Isenberg, D.A., Br. J. Haematol., 1991, vol. 77, pp. 354–359.
Hart, D.A. and Fritzler, M.J., J. Rheumatol., 1989, vol. 16, pp. 1184–1191.
Castellino, F.J. and Ploplis, V.A., Thromb. Haemost., 2005, vol. 93, pp. 647–654.
Mogues, T., Etzerodt, M., Hal, C., Engelich, G., Graversen, J.H., and Hartshorn, K.L., J. Biomed. Biotechnol., 2004, vol. 2, pp. 73–78.
Zorio, E., Gilabert-Estellés, J., España, F., Ramón, L.A., Cosín, R., and Estellés, A. Curr. Med. Chem., 2008, vol. 15, pp. 923–929.
Dano, K., Behrendt, N., Hoyer-Hansen, G., Johnsen, M., Lund, L.R., Ploug, M., and Romer, J., Thromb. Haemost., 2005, vol. 93, pp. 676–681.
Almholt, K., Lund, L.R., Rygaard, J., Nielsen, B.S., Dano, K., Romer, J., and Johnsen, M., Int. J. Cancer., 2005, vol. 113, pp. 525–532.
Collen, D. and Lijnen, H.R., Thromb. Haemost., 2005, vol. 93, pp. 627–630.
Melchor, J.P. and Strickland, S., Thromb. Haemost., 2005, vol. 93, pp. 655–660.
Yang, C.D., Hwang, K.K., Yan, W., Gallagher, K., FitzGerald, J., Grossman, J.M., Hahn, B.H., and Chen, P.P., J. Immunol., 2004, vol. 172, pp. 5765–5773.
Kolev, K., Gombas, J., Varadi, B., Skopál, J., Mede, K., Pitlik, E., Nagy, Z., and Machovich, R., Thromb. Haemost., 2002, vol. 87, pp. 502–508.
Lu, C.S., Horizon, A.A., Hwang, K.K., FitzGerald, J., Lin, W.S., Hahn, B.H., Wallace, D.J., Metzger, A.L., Weisman, M.H., and Chen, P.P., Arthritis Rheum., 2005, vol. 52, pp. 4018–4027.
Cugno, M., Cabibbe, M., Galli, M., Meroni, P.L., Caccia, S., Russo, R., Bottasso, B., and Mannucci, P.M., Blood, 2004, vol. 103, pp. 2121–2126.
Bu, C., Zhang, C., Li, Z., Gao, L., Xie, Z., and Gai, G., Clin. Exp. Immunol., 2007, vol. 149, pp. 31–39.
Violi, F., Ferro, D., Valesini, G., Quintarelli, C., Saliola, M., Grandilli, M.A., and Balsano, F., BMJ, 1990, vol. 300, pp. 1099–1102.
Nilsson, T.V. and Lofvenberg, E., Clin. Rheumatol., 1989, vol. 8, pp. 58–63.
Francis, R.B., McGehee, W.G., and Fernstein, D.I., Thromb. Haemost., 1988, vol. 59, pp. 412–414.
Mackworth-Young, C.G., Andreotti, F., Harmer, H., Loizou, S., Pottinger, B.E., Pearson, J.D., Davies, G.J., Maseri, A., and Walport, M.J., Br. J. Rheumatol., 1995, vol. 34, pp. 201–206.
Dawson, S., Hamsten, A., Wiman, B., Henney, A., and Humphries, S., Arterioscler. Thromb., 1991, vol. 11, pp. 183–190.
van Goor, M.L., García, E.G., Leebeek, F., Brouwers, G.J., Koudstaal, P., and Dippel, D., Thromb. Haemost., 2005, vol. 93, pp. 92–96.
Eriksson, P., Kallin, B., van Hooft, F.M., Bavhenolm, P., and Hamsten, A., Proc. Nat. Acad. Sci. USA, 1995, vol. 92, pp. 1851–1855.
Aisina, R.B., Levashov, M.Yu., Mukhametova, L.I., Gershkovich, K.B., and Gulin, D.A., Post-genomnye issledovanmiya i tekhnologii (Postgenomic Studies and Technologies), Varfolomeev, S.D., Ed., Moscow: Moscow State University, 2011, pp. 530–564.
Yasuda, S., Tsutsumi, A., Atsumi, T., Bertolaccini, M.L., Ichikawa, K., Khamashta, M.A., Hughes, G.R., and Koike, T., J. Rheumatol., 2002, vol. 29, pp. 1192–1197.
Tassies, D., Espinosa, G., Munoz-Rodriguez, F.J., Freire, C., Cervera, R., Monteagudo, J., Maragall, S., Escolar, G., Ingelmo, M., Ordinas, A., Font, J., and Reverter, J.C., Arthritis Rheum., 2000, vol. 43, pp. 2349–2258.
Hochberg, M.C., Arthritis Rheum., 1997, vol. 40, p. 1725.
Myakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., de Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G., and Krilis, S.A., J. Thromb. Haemost., 2006, vol. 4, pp. 295–306.
Brandt, J.T., Triplett, D.A., Alving, B., and Scharrer, I., Thromb. Haemost., 1995, vol. 74, pp. 1185–1190.
Brandt, J.T., Barna, L.K., and Triplett, D.A., Thromb. Haemost., 1995, vol. 74, pp. 1597–1603.
Barkagan, Z.S. and Momot, A.P., Diagnostika i kontroliruemaya terapiya narushenii gemostaza (Diagnostics and Controlled Therapy of Hemostasis Impairments), Moscow: NewDiamed, 2001.
Aleksandrova, E.N., Novikov, A.A., Reshetnyak, T.M., Popkova, T.V., Cherkasova, M.V., Diatroptova, M.A., Mach, E.S., Denisov, L.N., and Nasonov, E.L., Kliniko-Laboratornyi Konsilium, 2009, no. 2, pp. 47–58.
Sartori, M.T., Simioni, P., Patrassi, G.M., Theodoridis, P., Tormene, D., and Girolami, A., Thromb. Haemost., 2000, vol. 6, pp. 36–40.
Gonzalez-Gronow, M., Cuchacovich, M., Grigg, D.M., and Pizzo, S.V., J. Mol. Med., 1996, vol. 74, pp. 453–469.
Kozmin, L.D., Shirokova, I.E., Lisitsina, T.A., Popkova, T.V., Reschetnyak, T.M., Belenkiy, A.G., Martynov, A.I., and Bliznukov, O.P., Biochemistry (Moscow), 2003, vol. 68, pp. 339–345.
Jansson, J.H., Olofsson, B.O., and Nilsson, T.K., Circulation, 1993, vol. 88, pp. 2030–2034.
Ridker, P.M., Baker, M.T., Hennekens, C.H., Stampfer, M.J., and Vaughan, D.E., Arterioscler. Thromb. Vasc. Biol., 1997, vol. 17, pp. 1687–1690.
Thompson, S.G., Kienast, J., Pyke, S.D., Haverkate, F., and van de Loo, J.C., N. Engl. J. Med., 1995, vol. 332, pp. 635–641.
Kawai, Y., Matsumoto, Y., Watanabe, K., Yamamoto, H., Satoh, K., Murata, M., Handa, M., and Ikeda, Y., Blood, 1996, vol. 87, pp. 2314–2321.
Booth, N.A., Fibrinolysis Proteolysis, 2000, vol. 14, pp. 206–213.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © R.B. Aisina, L.I. Mukhametova, E.V. Ostryakova, N.V. Seredavkina, L.I. Patrushev, N.L. Patrusheva, T.M. Reshetnyak, D.A. Gulin, K.B. Gershkovich, E.L. Nasonov, S.D. Varfolomeyev, 2013, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Aisina, R.B., Mukhametova, L.I., Ostryakova, E.V. et al. Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thromboses in patients with the antiphospholipid syndrome. Biochem. Moscow Suppl. Ser. B 7, 1–15 (2013). https://doi.org/10.1134/S1990750813010010
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750813010010